219A JPX Week ended 07 Aug 2026

Weekly Investor Report

HEARTSEED INC · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 1,812 JPY
7.7% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 1.4% above the Trend Line and sits at 18.2% of its 52-week range. The latest completed week returned 7.7%, after a 12.6% four-week move. The latest news-sentiment score is 52/100.

Setup score 35 out of 100
Latest Close 1,812 JPY 7 Aug 2026
1W Return 7.7% latest completed week
4W Return 12.6% short-term follow-through
12W Return 1.6% quarterly tape
Trend Breadth 17.3% 9 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 7.7% Latest completed week; four-week move 12.6%. Indicator stack 10/69 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 52/100 6 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 1.4% above the Trend Line and sits at 18.2% of its 52-week range. The latest completed week returned 7.7%, after a 12.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0712-week average 0.13

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.07Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 12.6% over four weeks, 1.6% over 12 weeks, and -48.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W7.7%
4W12.6%
12W1.6%
26W-2.6%
52W-48.0%
Active trend streak0 weeks
Active weeks in one year9
Trend breadth17.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.33Latest activity-pressure read.
Pressure change156.7%Four-week change in activity pressure.
Leadership-28.43Latest relative-leadership reading.
RS change37.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 6 relevant articles.

1 positive · 5 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-53.8%Distance below the 52-week high.
13-week volatility6.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+11.7%Week of 24 Jul.
Worst week-9.0%Week of 22 May.
Latest week+7.7%Week of 7 Aug.

Shape of recent returns

Strong gains5
Modest gains9
Flat weeks0
Modest losses5
Sharp losses7
Recent vol6.4%13-week weekly-return volatility.
Base vol8.9%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew4.4% / -5.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape28/100

Trend, activity pressure, participation, and risk combine to a 28/100 tape read.

 Indicator analysis13/100

Latest 12-week confirmation: trend 0/12, activity pressure 2/12, relative leadership 0/12.

Activity pressure 0.07; No reversal markers Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment52/100

Weighted news tone is neutral across 6 relevant articles.

Heartseed, Inc. Revenue Breakdown – TSE:219A Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20261,812 JPY7.7%1,787 JPY2,104 JPY0.33-28.43815.5KOff
31 Jul 20261,683 JPY0.8%1,788 JPY2,107 JPY0.03-34.071.0MOff
24 Jul 20261,670 JPY11.7%1,792 JPY2,111 JPY-0.25-36.711.1MOff
17 Jul 20261,495 JPY-7.1%1,797 JPY2,115 JPY-0.56-44.52889.3KOff
10 Jul 20261,609 JPY-2.0%1,809 JPY2,121 JPY-0.59-45.65910.5KOff
3 Jul 20261,641 JPY6.8%1,820 JPY2,126 JPY-0.80-47.03182.8KOff
26 Jun 20261,536 JPY-7.1%1,826 JPY2,131 JPY-0.93-51.12168.8KOff
19 Jun 20261,654 JPY3.2%1,832 JPY2,137 JPY-0.92-49.68266.6KOff
12 Jun 20261,603 JPY-3.3%1,834 JPY2,142 JPY-0.83-48.67460.2KOff
5 Jun 20261,657 JPY7.5%1,840 JPY2,147 JPY-0.62-48.95452.9KOff
29 May 20261,542 JPY-4.9%1,844 JPY2,152 JPY-0.42-53.231.1MOff
22 May 20261,622 JPY-9.0%1,850 JPY2,159 JPY-0.27-49.381.9MOff
15 May 20261,783 JPY-1.3%1,854 JPY2,165 JPY-0.21-43.50890.3KOff
8 May 20261,807 JPY0.2%1,856 JPY2,169 JPY-0.11-44.66234.6KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.